CTLA4 and cancer: As no large-scale dataset with matched structural biology and genomic readouts currently exists to perform systematic analyses, we focus on PD-1/PD-L1 and B7–1/CTLA-4 interacting proteins, important immune checkpoint protein interactors involved in cancer immunotherapies [36].